146 related articles for article (PubMed ID: 1907825)
1. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
Griswold DE; Marshall PJ; Lee JC; Webb EF; Hillegass LM; Wartell J; Newton J; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):825-31. PubMed ID: 1907825
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Hanna N; Marshall PJ; Newton J; Schwartz L; Kirsh R; Dimartino MJ; Adams J; Bender P; Griswold DE
Drugs Exp Clin Res; 1990; 16(4):137-47. PubMed ID: 2127565
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
Griswold DE; Hoffstein S; Marshall PJ; Webb EF; Hillegass L; Bender PE; Hanna N
Inflammation; 1989 Dec; 13(6):727-39. PubMed ID: 2559032
[TBL] [Abstract][Full Text] [Related]
5. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002.
Griswold DE; Webb E; Schwartz L; Hanna N
Inflammation; 1987 Jun; 11(2):189-99. PubMed ID: 3108157
[TBL] [Abstract][Full Text] [Related]
7. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
8. Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Griswold DE; Marshall P; Martin L; Webb EF; Zabko-Potapovich B
Agents Actions Suppl; 1991; 32():113-7. PubMed ID: 1906235
[TBL] [Abstract][Full Text] [Related]
9. Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses.
Reddy MP; Webb EF; Cassatt D; Maley D; Lee JC; Griswold DE; Truneh A
Int J Immunopharmacol; 1994 Oct; 16(10):795-804. PubMed ID: 7843851
[TBL] [Abstract][Full Text] [Related]
10. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
11. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.
Griswold DE; Hillegass LM; Breton JJ; Esser KM; Adams JL
Drugs Exp Clin Res; 1993; 19(6):243-8. PubMed ID: 8013267
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
Griswold DE; Webb EF; Breton J; White JR; Marshall PJ; Torphy TJ
Inflammation; 1993 Jun; 17(3):333-44. PubMed ID: 7687237
[TBL] [Abstract][Full Text] [Related]
13. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
14. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro.
Votta BJ; Bertolini DR
Bone; 1994; 15(5):533-8. PubMed ID: 7980964
[TBL] [Abstract][Full Text] [Related]
15. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes.
Griswold DE; Martin LD; Badger AM; Breton J; Chabot-Fletcher M
Inflamm Res; 1998 Feb; 47(2):56-61. PubMed ID: 9535542
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.
DiMartino MJ; Griswold DE; Berkowitz BA; Poste G; Hanna N
Agents Actions; 1987 Feb; 20(1-2):113-23. PubMed ID: 3107354
[TBL] [Abstract][Full Text] [Related]
19. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]